Primary Site >> Colorectal Cancer

Gene >> PDLIM4

  • 1992
  • 1993
  • 1994
  • 1998
  • 1999
  • 2007
  • 2009
  • 2011
  • 2012
  • 2013
  • 2015
Ref: Interleukin 2 therapy in cancer: identification of responders.
PMID: 1457363
Ref: [Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
PMID: 1530292
Ref: Peri-operative modulation of cellular immunity in patients with colorectal cancer.
PMID: 8403515
Ref: Phenotypical and functional characteristics of tumor-infiltrating lymphocytes from colon carcinomas stimulated with rIL-2 and rIL-4 in vitro: comparison with lymphocytes of the normal colon mucosa and the peripheral blood.
PMID: 8074499
Ref: Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.
PMID: 9569042
Ref: Influence of cytokines on the expression of fas ligand and CD44 splice variants in colon carcinoma cells.
PMID: 10567875
Ref: RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis.
PMID: 17332327
Ref: Purification of caudal-related homeodomain transcription factor and its binding characterization.
PMID: 20075618
Ref: [Expression of mucin regulated by recombinant human interleukin-6 in HT-29 cell of colon cancer].
PMID: 22116730
Ref: Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island.
PMID: 22600741
Ref: Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran/PLGA-PLA core/shell microspheres.
PMID: 23624084
Ref: Epigenetic synergy between decitabine and platinum derivatives.
PMID: 26366234